Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Heat Biologics stock (HTBX)

Buy Heat Biologics stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Heat Biologics is a biotechnology business based in the US. Heat Biologics shares (HTBX) are listed on the NYSE and all prices are listed in US Dollars. Heat Biologics employs 49 staff and has a trailing 12-month revenue of around $2.1 million.

Our top picks for where to buy Heat Biologics stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Best for beginners

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for cash sweep

Go to site
Advanced charts and trading tools
  • Trade stocks, ETFs and equity options without commission and $0 option contract fees
  • Earn up to 8.1% APY on your uninvested cash
  • Get a 1.5% match in cash on transferred assets up to $300 or up to 15 free fractional shares worth between $2 and $2,000

How to buy Heat Biologics stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – HTBX. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Heat Biologics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder Score: 4.4 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
Stocks, Options, Mutual funds, ETFs, Alternatives
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Finder Score: 4.3 / 5: ★★★★★
Stocks, Options, ETFs
Up to 8.10%
Choose a 1.5% match or up to 15 free fractional shares
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Finder Score: 4.2 / 5: ★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Heat Biologics stock price (NYSE: HTBX)

Use our graph to track the performance of HTBX stocks over time.

Heat Biologics shares at a glance

Information last updated 2022-08-28.
Latest market close$2.55
52-week range$0.00 - $0.00
50-day moving average $2.57
200-day moving average $4.11
Wall St. target price$11.38
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.41

Is it a good time to buy Heat Biologics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Heat Biologics price performance over time

Historical closes compared with the close of $2.55 from 2022-07-01

1 week (2024-07-02) N/A
1 month (2024-06-09) N/A
3 months (2024-04-09) N/A
6 months (2024-01-09) N/A
1 year (2023-07-09) N/A
2 years (2022-07-09) N/A
3 years (2021-07-13) 6.43
5 years (2019-07-12) 4.697

Heat Biologics financials

Revenue TTM $2.1 million
Gross profit TTM $-16,708,472
Return on assets TTM -17.1%
Return on equity TTM -31.12%
Profit margin 0%
Book value $4.41
Market Capitalization $72.6 million

TTM: trailing 12 months

Heat Biologics share dividends

We're not expecting Heat Biologics to pay a dividend over the next 12 months.

Have Heat Biologics's shares ever split?

Heat Biologics's shares were split on a 1:7 basis on 10 December 2020. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Heat Biologics shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Heat Biologics shares which in turn could have impacted Heat Biologics's share price.

Heat Biologics share price volatility

Over the last 12 months, Heat Biologics's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Heat Biologics's is 0.3049. This would suggest that Heat Biologics's shares are less volatile than average (for this exchange).

Heat Biologics overview

NightHawk Biosciences, Inc. , an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate and expand T-cells; and ComPACT, which delivers antigen driven T-cell activation and specific co-stimulation in a single product. The company develops HS-110, which has completed enrollment in a Phase II clinical trial to treat patients with advanced non-small cell lung cancer; and HS-130 that is in Phase I clinical trial for the treatment of advanced solid tumors. Its products also include PTX-35, a novel T-cell co-stimulator agonist antibody targeting DR3/TNFRSF25 that is in Phase I clinical trial; DR3/TNFRSF25 for various immunotherapy approaches; and COVID-19 vaccine, which is in preclinical stage. The company has a collaboration with Dr.

Frequently asked questions

What percentage of Heat Biologics is owned by insiders or institutions?
Currently 5.201% of Heat Biologics shares are held by insiders and 10.76% by institutions.
How many people work for Heat Biologics?
Latest data suggests 49 work at Heat Biologics.
When does the fiscal year end for Heat Biologics?
Heat Biologics's fiscal year ends in December.
Where is Heat Biologics based?
Heat Biologics's address is: 627 Davis Drive, Morrisville, NC, United States, 27560
What is Heat Biologics's ISIN number?
Heat Biologics's international securities identification number is: US42237K4094
What is Heat Biologics's CUSIP number?
Heat Biologics's Committee on Uniform Securities Identification Procedures number is: 42237K300

More guides on Finder

Ask a Question provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site